Skip header and navigation

Refine By

5 records – page 1 of 1.

[Forms of organization of ambulatory treatment of children with diseases of the weight-bearing motor apparatus in the system of dispensary observation in Sverdlovsk]

https://arctichealth.org/en/permalink/ahliterature44438
Source
Ortop Travmatol Protez. 1968 Dec;29(12):39-41
Publication Type
Article
Date
Dec-1968

[Natural gas-steam-thermal springs in combined therapy of osteomuscular system diseases].

https://arctichealth.org/en/permalink/ahliterature169000
Source
Vopr Kurortol Fizioter Lech Fiz Kult. 2006 Jan-Feb;(1):24-7
Publication Type
Article
Author
R R Badretdinov
A A Fomin
L M Badretdinova
Source
Vopr Kurortol Fizioter Lech Fiz Kult. 2006 Jan-Feb;(1):24-7
Language
Russian
Publication Type
Article
Keywords
Balneology - methods
Bashkiria
Baths - methods
Bone Diseases - therapy
Gases - therapeutic use
Health Resorts
Humans
Muscular Diseases - therapy
Steam Bath - methods
Treatment Outcome
Abstract
The article describes effects of unique thermal springs of Yangan-Tau mountain in patients with locomotor diseases. Effects of gas, steam and thermal factors of the water from the above springs were studied in patients with rheumatoid arthritis who took baths in the sanatorium Yangan-Tau. Changes in the cytokine profile of the patients were analysed.
PubMed ID
16752740 View in PubMed
Less detail

[Organizational problems of santorium-health resorts for the treatment of children with diseases of the locomotor apparatus].

https://arctichealth.org/en/permalink/ahliterature110712
Source
Zdravookhr Ross Fed. 1968 Apr;12(4):3-5
Publication Type
Article
Date
Apr-1968
Author
M V Svirezhev
R A Iakovleva
Source
Zdravookhr Ross Fed. 1968 Apr;12(4):3-5
Date
Apr-1968
Language
Russian
Publication Type
Article
Keywords
Child
Health Resorts
Humans
Joint Diseases - therapy
Muscular Diseases - therapy
Russia
PubMed ID
4243941 View in PubMed
Less detail

Variability in the clinical management of fatty acid oxidation disorders: results of a survey of Canadian metabolic physicians.

https://arctichealth.org/en/permalink/ahliterature134037
Source
J Inherit Metab Dis. 2012 Jan;35(1):115-23
Publication Type
Article
Date
Jan-2012
Author
Beth K Potter
Julian Little
Pranesh Chakraborty
Jonathan B Kronick
Jessica Evans
Julia Frei
Sarah C Sutherland
Kumanan Wilson
Brenda J Wilson
Author Affiliation
Department of Epidemiology & Community Medicine, University of Ottawa, 451 Smyth Rd, Ottawa, Ontario, Canada. bpotter@uottawa.ca
Source
J Inherit Metab Dis. 2012 Jan;35(1):115-23
Date
Jan-2012
Language
English
Publication Type
Article
Keywords
3-Hydroxyacyl CoA Dehydrogenases - deficiency
Acyl-CoA Dehydrogenase - deficiency
Acyl-CoA Dehydrogenase, Long-Chain - deficiency
Canada
Carnitine - therapeutic use
Dietary Fats
Fatty Acids - metabolism
Health Knowledge, Attitudes, Practice
Humans
Lipid Metabolism, Inborn Errors - diagnosis - therapy
Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase
Mitochondrial Diseases - therapy
Mitochondrial Trifunctional Protein
Multienzyme Complexes - deficiency
Muscular Diseases - therapy
Oxygen - chemistry
Questionnaires
Abstract
There is little robust empirical evidence on which to base treatment recommendations for fatty acid oxidation disorders. While consensus guidelines are important, understanding areas where there is a lack of consensus is also critical to inform priorities for future evaluative research.
We surveyed Canadian metabolic physicians on the treatment of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency, very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency, long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency, and mitochondrial trifunctional protein (MTP) deficiency. We ascertained physicians' opinions on the use of different interventions for the long-term management of patients as well as for the management of acute illness, focusing on identifying interventions characterized by high variability in opinions. We also investigated factors influencing treatment decisions.
We received 18 responses (response rate 45%). Participants focused on avoidance of fasting and increased meal frequency as interventions for the management of MCAD deficiency. For the long-chain disorders, avoidance of fasting remained the most consistently endorsed intervention, with additional highly endorsed treatments differing for VLCAD versus LCHAD/MTP deficiency. L-carnitine supplementation and restriction of dietary fat were characterized by high variability in physicians' opinions, as were several interventions specific to long-chain disorders. Social factors and patient characteristics were important influences on treatment decisions.
Based on our findings we suggest that high priority treatments for rigorous effectiveness studies could include L-carnitine supplementation (MCAD and LCHAD/MTP deficiencies), restriction of dietary fat, and, for the long-chain disorders, feeding practices for breastfed infants and the use of various supplements (essential fatty acids, carbohydrates, cornstarch, multivitamins).
PubMed ID
21630065 View in PubMed
Less detail